Regeneron Pharmaceuticals
REGN
#131
Rank
$118.85 B
Marketcap
$1,079
Share price
-1.49%
Change (1 day)
49.49%
Change (1 year)

Operating Margin for Regeneron Pharmaceuticals (REGN)

Operating Margin as of July 2024 (TTM): 37.68%

According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 37.68%. At the end of 2022 the company had an Operating Margin of 39.91%.

Operating Margin history for Regeneron Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202239.91%-31.21%
202158.03%29.4%
202044.84%45.17%
201930.89%-18.82%
201838.05%7.5%
201735.40%29.37%
201627.36%-8.35%
201529.85%8.51%
201427.51%-18.82%
201333.89%12.74%
201230.06%-160.13%
2011-50.00%119.7%
2010-22.76%19.95%
2009-18.97%-43.7%
2008-33.70%-63.19%
2007-91.55%-46.05%
2006-169.68%-190.27%
2005187.97%5693.39%
20043.24%-101.87%
2003-173.90%-68.65%
2002-554.63%42.23%
2001-389.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
34.59%-8.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-108.63%-388.30%๐Ÿ‡บ๐Ÿ‡ธ USA
31.30%-16.93%๐Ÿ‡บ๐Ÿ‡ธ USA
22.88%-39.28%๐Ÿ‡บ๐Ÿ‡ธ USA
17.27%-54.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
18.21%-51.67%๐Ÿ‡ซ๐Ÿ‡ท France

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.